लोड गर्दै

Slzii.com खोज्नुहोस्

खोज्नुहोस् (समाचार)

ITM To Announce Quality Of Life Data From The Phase 3 COMPETE Trial In Patients With Gastroenteropancreatic Neuroendocrine Tumors (GEP-Nets) At ASCO 2026

health top

(MENAFN - GlobeNewsWire - Nasdaq) Garching / Munich, April 21, 2026 –– ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will ...
2026-04-21 10:46:34

के गर्दै हुनुहुन्छ?

0.072780847549438


समाचार
समाचार

ताजा समाचार र हेडलाइनहरू
(MENAFN - GlobeNewsWire - Nasdaq) Garching / Munich, April 21, 2026 –– ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutic...
समाचार